Twenty billion dollars a year… That’s how much Americans in chronic pain spend on prescription pain-killers every year. Most of these are opioid drugs, but the increasing regulatory burden foisted on them and the growing realization of how ineffective and...
Nobody mentioned viruses and fibromyalgia in the same sentence until Dr. Pridgen had the gall to assert a virus was causing FM, and that he had the patient reports to prove it. There’s nothing easy bringing a drug to market, though. With his Phase II study...
Drug companies interested in ME/CFS? A race to produce the first drug for ME/CFS? A race? Those almost sound like fantasies but that’s the message Jarred Younger brought in his recent video talk. The bottom line, he said, is that over the last three months he’s...
Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial. Check out what happened with it, and...
Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...
If you live in the U.S. where drugs typically cost 2-6 times more than elsewhere, drug bills can really add up. Buying drugs from international pharmacies can save U.S. consumers a lot of money – but is it safe? Health Rising takes a look in that issue in Buying...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.